Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus.
暂无分享,去创建一个
V. D’Agati | R. Lifton | A. Gharavi | P. Klotman | Zongyu Zheng | N. Papeta | K. Chan | Jeremiah Martino | Rachelle Z Frankel
[1] D. Reich,et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.
[2] D. Vlahov,et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.
[3] Marni J. Falk,et al. Primary Coenzyme Q Deficiency in Pdss2 Mutant Mice Causes Isolated Renal Disease , 2008, PLoS genetics.
[4] R. Iyengar,et al. HIV-1 Nef Disrupts the Podocyte Actin Cytoskeleton by Interacting with Diaphanous Interacting Protein* , 2008, Journal of Biological Chemistry.
[5] J. Henderson,et al. Mice with altered alpha-actinin-4 expression have distinct morphologic patterns of glomerular disease. , 2008, Kidney international.
[6] V. D’Agati. Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). , 2008, Kidney international.
[7] Eleazar Eskin,et al. A sequence-based variation map of 8.27 million SNPs in inbred mouse strains , 2007, Nature.
[8] A. Lalwani,et al. Generation and Characterization of Mice with Myh9 Deficiency , 2007, NeuroMolecular Medicine.
[9] A. Gharavi,et al. Genetic susceptibility, HIV infection, and the kidney. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[10] P. Janmey,et al. HIV infection changes glomerular podocyte cytoskeletal composition and results in distinct cellular mechanical properties. , 2007, American journal of physiology. Renal physiology.
[11] Li-jun Ma,et al. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. , 2006, Journal of the American Society of Nephrology : JASN.
[12] P. Pavlidis,et al. An ancestral haplotype defines susceptibility to doxorubicin nephropathy in the laboratory mouse. , 2006, Journal of the American Society of Nephrology : JASN.
[13] P. Ramdial,et al. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. , 2006, Kidney international.
[14] I. Katz,et al. HIV-related nephropathy: a South African perspective. , 2006, Kidney international.
[15] Scott Martinka,et al. Persistent NF-κB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy , 2006 .
[16] V. D’Agati,et al. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN , 2005, AIDS.
[17] L. Holzman,et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. , 2005, Journal of the American Society of Nephrology : JASN.
[18] M. Madaio,et al. The kd/kd mouse is a model of collapsing glomerulopathy. , 2005, Journal of the American Society of Nephrology : JASN.
[19] T. Matsusaka,et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. , 2005, Kidney international.
[20] V. D’Agati,et al. NF-κB regulates Fas-mediated apoptosis in HIV-associated nephropathy , 2005 .
[21] B. Rovin,et al. The Influence of CCL 3 L 1 Gene – Containing Segmental Duplications on HIV-1 / AIDS Susceptibility , 2009 .
[22] T. Naoe,et al. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice. , 2004, Biochemical and biophysical research communications.
[23] R. Iyengar,et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. , 2004, The Journal of clinical investigation.
[24] V. D’Agati,et al. Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] Robert W. Williams,et al. The nature and identification of quantitative trait loci: a community's view , 2003, Nature Reviews Genetics.
[26] J. He,et al. Critical role for Nef in HIV-1-induced podocyte dedifferentiation. , 2003, Kidney international.
[27] E. Unanue,et al. CD2-Associated Protein Haploinsufficiency Is Linked to Glomerular Disease Susceptibility , 2003, Science.
[28] Hao Wu,et al. R/qtl: QTL Mapping in Experimental Crosses , 2003, Bioinform..
[29] V. D’Agati,et al. Pathologic classification of focal segmental glomerulosclerosis. , 2003, Seminars in nephrology.
[30] C. Moore,et al. Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.
[31] V. D’Agati,et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. , 2001, The New England journal of medicine.
[32] P. Fine,et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. , 2001, Journal of the American Society of Nephrology : JASN.
[33] V. D’Agati,et al. J Am Soc Nephrol 11: 2079–2087, 2000 Renal Epithelium Is a Previously Unrecognized Site of HIV-1 Infection , 2022 .
[34] V. D’Agati,et al. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. , 2000, Kidney international.
[35] B. Freedman,et al. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] P. Klotman,et al. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. , 1999, Kidney international.
[37] Lars Lannfelt,et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy , 1998, Nature Medicine.
[38] J J Goedert,et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.
[39] E. Lander,et al. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.
[40] P. Klotman,et al. Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. , 1993, AIDS research and human retroviruses.
[41] P. Klotman,et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] Scott Martinka,et al. Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy. , 2006, American journal of physiology. Renal physiology.
[43] V. D’Agati,et al. NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[44] R. Ravazzolo,et al. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[45] M. Soto,et al. Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features. , 2003, Kidney international.
[46] G. Appel,et al. Collapsing glomerulopathy. , 2003, Seminars in nephrology.
[47] A. Darvasi,et al. Experimental strategies for the genetic dissection of complex traits in animal models , 1998, Nature Genetics.
[48] V. D’Agati,et al. HIV infection and the kidney. , 1997, Journal of the American Society of Nephrology : JASN.